The FTC approved the deal in a 3-1 vote following a eight-month investigation, despite criticism from several politicians and trade groups that the deal will have an adverse impact on community pharmacies.

“Ultimately, the evidence fails to demonstrate that the transaction is likely to produce unilateral anti-competitive effects,” the FTC...